OBM Transplantation

(ISSN 2577-5820)

OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 

Indexing: DOAJ-Directory of Open Access Journals.

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 6 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 3.7 weeks (median values) after submission.

Current Issue: 2020  Archive: 2019 2018 2017

Special Issue

COVID-19 and Organ Transplantation

Submission Deadline: February 15, 2021 (Open) Submit Now

Guest Editor

Kamal Kant Sahu, MD

Department of Hematology and Oncology, Saint Vincent Hospital, Worcester, MA 01608, USA

Website | E-Mail

Research Interests: Acute myeloid leukemia; stem cell transplantation; leukemia; lymphoma; chemotherapy; myelodysplastic syndromes; multiple myeloma

About This Topic

Currently, world is fighting against an invisible enemy, SARS-CoV-2 virus and its disease (COVID-19 disease). Data so far suggests that effects of COVID-19 is more in individuals older than 65 years, male gender, and individuals with multiple comorbidities. Lately, few studies from China have shown a higher incidence of COVID-19 disease amongst cancer patients than in general population. However, that needs to be confirmed in other countries. Similarly, other immunosuppressed individuals like transplant recipients especially who are on immunosuppressants have diminished fighting response in general. Similarly, it is challenging for the transplant specialists to do transplantation during this COVID-19 crisis. Various societies around the world are providing their expert opinions but still lots of work still needs to be done to streamline the smooth functioning of the transplant procedure of various organs. We hereby encourage young scholars, researchers, and transplant specialists to submit to us their opinion, experience and personal views on this crucial topic.

Newsletter

TOP